Exploring the self-efficacy and self-care-based stroke care model for risk factor modification in mild-to-moderate stroke patients

CONTEXT: The worldwide burden of stroke is projected to grow unless proper stroke education is implemented. Information alone cannot promote patient self-efficacy and self-care and reduce risk factors. AIM: This trial aimed to test self-efficacy and self-care-based stroke education (SSE) on changes in self-efficacy, self-care, and risk factor modification. DESIGN, SETTING, AND PARTICIPANTS: This study is a single-center, double-blinded, interventional, two-arm randomized controlled trial with a 1- and 3-month follow-up in Indonesia. Between January 2022 and October 2022, 120 patients were prospectively enrolled from Cipto Mangunkusumo National Hospital, Indonesia. Participants were assigned using a computer-generated random number list. INTERVENTION: SSE was given before discharge from the hospital. PRIMARY OUTCOME MEASURE: Self-care, self-efficacy, and stroke risk score was measured 1 month and 3 months after discharge. SECONDARY OUTCOME MEASURE: Modified Rankin Scale, Barthel Index, and blood viscosity was measured at 1 month and 3 months after discharge. RESULTS: A total of 120 patients (intervention n = 60; standard care n = 60) were randomized. In the 1st month, the intervention group showed a more significant change in self-care (4.56 [95% CI: 0.57, 8.56]), self-efficacy (4.95 [95% CI: 0.84, 9.06]), and stroke risk (−2.33 [95% CI:−3.19, −1.47]) compared to the controlled group. In the 3rd month, the intervention group also showed a more significant change in self-care (19.28 [95% CI: 16.01, 22.56]), self-efficacy (19.95 [95% CI: 16.61, 23.28]), and stroke risk (−3.83 [95% CI: −4.65, −3.01]) compared to the controlled group. CONCLUSION: SSE may boost self-care and self-efficacy, adjust risk factors, enhance functional outcomes, and decrease blood viscosity. CLINICAL TRIAL REGISTRATION: ISRCTN11495822.